 |
|
|
|
|
|
|
|
|
|
|
|
|
CASE NOTES
|
 |
|
 |
MISSED A PROGRAMME?
Go to the Listen Again page |
|
|
|
|
|
|
PROGRAMME INFO |
|
|
|
|
|
DrÌýMark PorterÌýgives listeners the low-down on what the medical profession does and doesn't know. Each week an expert in the studio tacklesÌýa particular topic and there are reports from around the UK on the health of the nation - and the NHS.
|
|
|
|
|
|
Contact Case Notes |
|
|
|
|
LISTEN AGAIN Ìý30 min |
|
|
|
 |
PRESENTER |
|
|
|
 |
|
|
|
"I spend half my week practising medicine and the other half writing and talking about it as a GP in Gloucestershire. Working on Case Notes has been a boon for both me and my patients. One of the principal aims of the programme is to keep our listeners up-to-date with the latest developments in healthcare, and to accomplish that I get to interview a wide range of specialists at the cutting edge of medicine. A rare privilege that ensures our listeners aren't the only ones to learn something new."
Mark Porter
|
|
|
|
|
|
|
|
|
|
|
|
PROGRAMME DETAILS |
|
|
|
 |
|
|
 Full programme transcript >>
The Royal Marsden Hospital
Dr Mark Porter kicks off a new series of Case Notes with a special edition in which he visits the Royal Marsden Hospital to look at cancer therapies and research.
The hospital was the first in the world to be dedicated to the study and treatment of cancers.Ìý It wasÌýfounded in 1851 by Dr William Marsden after he lost his wife to the disease.
Recent Developments
The programme explores recent developments in a new type of radiotherapy, IMRT, which has the ability to target tumours of all shapes with ionising radiationÌýandÌýwith minimal damage to healthy tissue.
As clinical oncologist Vincent Khoo explains, this enables clinicians to deliver higher concentrations and more effective doses of radiation to the tumour than has been possible in the past -Ìýnow that healthy tissue in the tumour area escapes beingÌýirradiated too.
Genetics
Genetics is another key area in the battle against cancer: Dr Ros Eeles, consultant in clinical oncology and cancer genetics, discusses the extent to which a positive family history may be important in your predisposition to developing cancer.
Drug Development Unit
Stan Kaye, head of the Marsden's Drug Development Unit, discusses how genetics can also be used to identify particular changes that differentiate cancer cells from normal cells. This in turn can identify new targets for drugs such as Herceptin which is proving a major breakthrough in the treatment of breast cancer.
There's alsoÌýa visit to the Drug Development Unit where new drugs are being trialled for a range of cancers in new and innovative ways.
|
|
|
RELATED LINKS
The 91Èȱ¬ is not responsible for the content of external websites
|
|
|
|
|
|
